Who owns AURA BIOSCIENCES INC?
- Ticker: AURA
- CUSIP Number: 05153u107
Tip: Access positions for across all investors
Analyze quarterly positions in Aura Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aura Biosciences stock
Who bought or sold AURA BIOSCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Eventide Asset Management | 5.8M | $51M | 92% | Dec 2023 |
|
| Citadel Advisors | 3.6M | $32M | 46% | Dec 2023 |
|
| Medicxi Ventures Management | 3.0M | $24M | 0% | Mar 2024 |
|
| Vanguard Group | 1.7M | $15M | 68% | Dec 2023 |
|
| Nantahala Capital Management | 1.3M | $12M | 78% | Dec 2023 |
|
| Goldman Sachs Group | 1.0M | $9.2M | 4% | Dec 2023 |
|
| Regency Capital Management | 705k | $6.2M | 34% | Dec 2023 |
|
| T. Rowe Price Associates | 660k | $5.8M | 0% | Dec 2023 |
|
| Franklin Resources | 600k | $5.3M | 100% | Dec 2023 |
|
| Decheng Capital | 516k | $4.6M | 100% | Dec 2023 |
|
| Long Focus Capital Management | 340k | $3.0M | 74% | Dec 2023 |
|
| Monashee Investment Management | 198k | $1.8M | 100% | Dec 2023 |
|
| Dimensional Fund Advisors | 178k | $1.6M | 59% | Dec 2023 |
|
| TD Asset Management | 108k | $956k | 0% | Dec 2023 |
|
| Levin Capital Strategies | 100k | $886k | 23% | Dec 2023 |
|
| Charles Schwab Investment Management | 91k | $810k | 26% | Dec 2023 |
|
| Bank of New York Mellon | 90k | $800k | 8% | Dec 2023 |
|
| Alyeska Investment Group | 76k | $673k | 100% | Dec 2023 |
|
| TBH Global Asset Management | 60k | $535k | 82% | Dec 2023 |
|
| D. E. Shaw & Co | 60k | $532k | 100% | Dec 2023 |
|
| Hudson Bay Capital Management | 53k | $470k | 100% | Dec 2023 |
|
| Two Sigma Investments | 42k | $376k | 100% | Dec 2023 |
|
| Rhumbline Advisers | 40k | $353k | 0% | Dec 2023 |
|
| Exchange Traded Concepts | 38k | $300k | 156% | Mar 2024 |
|
| Barclays | 38k | $338k | 683% | Dec 2023 |
|
| Bank of America Corporation | 36k | $314k | -14% | Dec 2023 |
|
| ALPS Advisors | 34k | $298k | 20% | Dec 2023 |
|
| UBS Group | 31k | $275k | 4184% | Dec 2023 |
|
| State of Wisconsin Investment Board | 30k | $264k | 16% | Dec 2023 |
|
| Jane Street | 29k | $255k | 100% | Dec 2023 |
|
| Values First Advisors | 27k | $214k | 150% | Mar 2024 |
|
| SG Americas Securities | 19k | $170k | 52% | Dec 2023 |
|
| Jpmorgan Chase & Co | 18k | $163k | -2% | Dec 2023 |
|
| Walleye Trading Advisors | 18k | $160k | 100% | Dec 2023 |
|
| Trexquant Investment | 17k | $154k | 65% | Dec 2023 |
|
| MetLife Investment Advisors | 15k | $133k | 0% | Dec 2023 |
|
| Wealth Enhancement Advisory Services | 15k | $116k | 100% | Mar 2024 |
|
| American International | 14k | $122k | 1% | Dec 2023 |
|
| Alliancebernstein | 13k | $115k | 21% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 13k | $115k | 100% | Dec 2023 |
|
| Mirae Asset Global Investments | 12k | $110k | 0% | Dec 2023 |
|
| Deutsche Bank Aktiengesellschaft | 11k | $98k | -4% | Dec 2023 |
|
| Royal Bank of Canada | 11k | $93k | 92% | Dec 2023 |
|
| Wells Fargo & Company | 8.6k | $76k | 27% | Dec 2023 |
|
| New York State Common Retirement Fund | 6.4k | $57k | -1% | Dec 2023 |
|
| Citigroup | 4.0k | $36k | -96% | Dec 2023 |
|
| Legal & General Group | 2.3k | $21k | 0% | Dec 2023 |
|
| Summit Investment Advisors | 2.3k | $20k | 0% | Dec 2023 |
|
| Metropolitan Life Insurance Company | 1.6k | $14k | 0% | Dec 2023 |
|
| Amalgamated Bank | 1.2k | $10k | -42% | Mar 2024 |
|
| CWM | 40.00 | $0 | 8% | Mar 2024 |
|
| NISA Investment Advisors | 10.00 | $89.000000 | -99% | Dec 2023 |
|
Who sold out of Aura Biosciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Martingale Asset Management | Sep 2023 | 25k | $221k |
| GSA Capital Partners | Sep 2023 | 18k | $161k |
| Mariner Wealth Advisors | Sep 2023 | 11k | $96k |
| Fortitude Family Office | Dec 2023 | 227.00 | $2.0k |
| Coppell Advisory Solutions | Sep 2023 | 100.00 | $2.0k |